BiotechTube

atomoxetine (Strattera)

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

ADHD

Conditions

ADHD

Trial Timeline

Sep 1, 2004 → Sep 1, 2007

NCT ID
NCT00181948

About atomoxetine (Strattera)

atomoxetine (Strattera) is a approved stage product being developed by Eli Lilly for ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT00181948. Target conditions include ADHD.

What happened to similar drugs?

9 of 20 similar drugs in ADHD were approved

Approved (9) Terminated (3) Active (10)
✅atomoxetineEli LillyApproved
✅Strattera (atomoxetine)Eli LillyApproved
✅Atomoxetine + placeboEli LillyApproved
✅Atomoxetine Hydrochloride + placeboEli LillyApproved
🔄dasotraline + PlaceboSumitomo PharmaPhase 3
🔄dasotraline 4mgSumitomo PharmaPhase 3
🔄Focalin XRNovartisPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00181948ApprovedCompleted

Competing Products

20 competing products in ADHD

See all competitors
ProductCompanyStageHype Score
atomoxetineEli LillyApproved
39
Strattera (atomoxetine)Eli LillyApproved
43
Atomoxetine + placeboEli LillyApproved
43
Atomoxetine Hydrochloride + placeboEli LillyApproved
43
Atomoxetine + stimulants (any approved ADHD medication)Eli LillyPre-clinical
26
dasotraline + PlaceboSumitomo PharmaPhase 3
40
dasotralineSumitomo PharmaPhase 1
29
dasotraline 4mgSumitomo PharmaPhase 3
40
AZD1446 + AZD1446 + AZD1446 + PlaceboAstraZenecaPhase 2
35
Placebo + AZD3480 + AZD3480AstraZenecaPhase 2
35
MK0249 + Concerta (methylphenidate) + PlaceboMerckPhase 2
35
Focalin XRNovartisPhase 3
40
Dex-Methylphenidate hydrochloride Extended Release (Focalin® XR) + PlaceboNovartisApproved
43
Dexmethylphenidate HCl extended-release capsulesNovartisPhase 3
40
Methylphenidate hydrochlorideNovartisPhase 3
40
Focalin XRNovartisPhase 3
40
methylphenidate HCl ERCT + PlaceboPfizerApproved
35
methylphenidate HCl ERCTPfizerApproved
35
Very Low Dose Quillivant XR + Low Dose Quillivant XR + Moderate Dose Quillivant XRPfizerApproved
43
BrexpiprazoleLundbeckPhase 1
26